सत्यापित हो रहा है..
स्वचालित रूप से अनुवादित। खुराक और चेतावनियाँ: मूल अंग्रेज़ी में देखें। अंग्रेज़ी में पढ़ें

KPI Prednisolone Tablet

NAFDAC Reg. No. A4-7721 · दवा

NAFDAC के साथ रजिस्टर किया गया। रजिस्ट्रेशन ऐक्टिव हैAs of 30 October 2026 · synced automatically from official sources.
उत्पाद
KPI Prednisolone Tablet
NAFDAC नंबर
A4-7721
सक्रिय घटक
Prednisone
प्रबलता
5 mg
Form
Tablet
Pack size
10 x 10's (in PVC blisters)
Manufacturer
Not listed
Applicant (holder)
Krishat Pharma Industries Limited
Approved
6 Jul 2023
Status
Active View on NAFDAC ↗
Registration valid to
5 Jul 2028
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Prednisone: uses, dosage and brands worldwide

What we found

  • KPI Prednisolone Tablet is on the NAFDAC register with an active registration (A4-7721). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use KPI Prednisolone Tablet

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

यह किसके लिए है

INDICATIONS Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Hypercalcemia associated with cancer Nonsuppurative thyroiditis 2. …

How to take it and how often
  • The initial dosage of prednisone may vary from 5 mg to 60 mg of prednisone per day depending on the specific disease entity being treated
  • In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required
  • The initial dosage should be maintained or adjusted until a satisfactory response is noted
  • If after a reasonable period of time there is a lack of satisfactory clinical response, prednisone should be discontinued and the patient transferred to other appropriate therapy
  • IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT
  • After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached
  • It should be kept in mind that constant monitoring is needed in regard to drug dosage
  • Included in the situations which may make dosage adjustments necessary are changes in clinical status secondary to remissions or exacerbations in the disease process, the patient’s individual drug responsiveness, and the effect of patient exposure to stressful situations not directly related to the disease entity under treatment; in this latter situation it may be necessary to increase the dosage of prednisone for a period of time consistent with the patient’s condition. …
Talk to a doctor first if

Systemic fungal infections and known hypersensitivity to components.

Warnings

In patients on corticosteroid therapy subjected to unusual stress, increased dosage of rapidly acting corticosteroids before, during, and after the stressful situation is indicated. Corticosteroids may mask some signs of infection, and new infections may appear during their use. There may be decreased resistance and inability to localize infection when corticosteroids are used. Prolonged use of corticosteroids may produce posterior subcapsular cataracts, glaucoma with possible damage to the optic nerves, and may enhance the establishment of secondary ocular infections due to fungi or viruses. …

Possible side effects

Fluid and Electrolyte Disturbances Sodium retention Fluid retention Congestive heart failure in susceptible patients Potassium loss Hypokalemic alkalosis Hypertension Musculoskeletal Muscle weakness Steroid myopathy Loss of muscle mass Osteoporosis Tendon rupture, particularly of the Achilles tendon Vertebral compression fractures Aseptic necrosis of femoral and humeral heads Pathologic fracture of long bones Gastrointestinal Peptic ulcer with possible perforation and hemorrhage Pancreatitis Abdominal distention Ulcerative esophagitis Dermatologic Impaired wound healing Thin fragile skin Petechiae and ecchymoses Facial erythema Increased sweating May suppress reactions to skin tests Metaboli …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-08-31.

Label for prednisone, the active ingredient registered with NAFDAC.

Check your pack of KPI Prednisolone Tablet

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About KPI Prednisolone Tablet

What is in KPI Prednisolone Tablet?

KPI Prednisolone Tablet contains Prednisone (5 mg), as tablet, according to its NAFDAC registration record.

Is KPI Prednisolone Tablet registered with NAFDAC?

Yes. KPI Prednisolone Tablet is listed on the NAFDAC register under registration number A4-7721, and its registration is active as of 30 October 2026.

Has KPI Prednisolone Tablet been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches KPI Prednisolone Tablet in our automatically synced alert list.

How can I check that my pack of KPI Prednisolone Tablet is genuine?

Run a free authenticity scan with the NAFDAC number A4-7721, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take KPI Prednisolone Tablet?

Follow your prescription or the leaflet in your pack. The official label says: The initial dosage of prednisone may vary from 5 mg to 60 mg of prednisone per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasona…

What is KPI Prednisolone Tablet used for?

INDICATIONS Prednisone tablets are indicated in the following conditions: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) Congenital adrenal hyperplasia Hypercalcem (Summarised from the official U.S. FDA label for prednisone. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used KPI Prednisolone Tablet? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.